Matinas BioPharma Holdings, Inc. (MTNB) stock
MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.91+0.05 (+6.35%)
Close on Nov 18, 2026Market cap $13.37MP/E –Yield –
Matinas BioPharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Matinas BioPharma's market cap was $5.96M on Nov 11, 2026, against $66.38M a year earlier. Over the last 5 years it ranged from $5.96M to $3.28B, with a median of $526.17M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.96M | -88.5% |
| 2025 | Dec 31, 2025 | $51.87M | +33.3% |
| 2024 | Dec 31, 2024 | $38.91M | -94.5% |
| 2023 | Dec 29, 2023 | $704.55M | -56.7% |
| 2022 | Dec 30, 2022 | $1.63B | -50.4% |
| 2021 | Dec 31, 2021 | $3.28B | -19.3% |
| 2020 | Dec 31, 2020 | $4.06B | -26.7% |
| 2019 | Dec 31, 2019 | $5.54B | +535.4% |
| 2018 | Dec 31, 2018 | $871.90M | -46.1% |
| 2017 | Dec 29, 2017 | $1.62B | +33.0% |
| 2016 | Dec 30, 2016 | $1.22B | – |
See a number that looks wrong?